RB1 and prostate cancer: The importance of the TGFβRIII-p38MAPK-Rb signaling axis in maintaining dormancy was evaluated in patients with prostate cancer; lower TGFβRIII expression correlated with increased metastatic potential and decreased survival rates [89].